Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072)

NCT00111722 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

393

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: MK0462, rizatriptan benzoate / Duration of Treatment -1day
DRUG: Comparator: placebo / Duration of Treatment - 1 day

Sponsor

Organon and Co